Merck & Co. Pauses Enrollment Of Oral Islatravir In PrEP Studies As Bad News Mounts

 
• By Jessica Merrill
Pause Button
Merck paused enrollment in more studies testing Islatravir • Source: Alamy

More from Anti-infective

More from Therapeutic Category